Fulvestrant is used in the treatment of
HR positive metastatic breast cancer in post menopausal women
Male breast cancer
Paget's disease
Acute myeloid leukemia associated with Down's syndrome
Fulvestrant is a selective estrogen receptor downregulator (SERD) used in cases of hormone receptor positive metastatic breast carcinoma in post menopausal women.